The North America Urinalysis Market is expected to grow from US$ 1,432.01 million in 2021 to US$ 2,129.13 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028.
North America Urinalysis Market Overview
The urinalysis market features a mix of small and large companies competing through strategies such as new product launches, regional expansions, and technological advancements. The growing demand for rapid tests, point-of-care (PoC) testing, and portable instruments is driving innovation, with companies investing in R&D to develop advanced diagnostic solutions. PoC testing, in particular, is gaining traction due to its cost-effectiveness, quick results in non-laboratory settings, and ability to diagnose a wide range of diseases.
North America Urinalysis Market Segmentation and Growth Drivers
The North America Urinalysis Market is segmented into the U.S., Canada, and Mexico, with the U.S. dominating due to:
- High prevalence of chronic diseases
- Strong presence of key market players
- Extensive R&D initiatives by research institutes
- Increased public healthcare spending
- Rising awareness programs
Impact of COVID-19
The pandemic initially disrupted the market as lockdowns delayed routine health checkups, reducing test volumes and sales of urinalysis instruments and consumables. However, as restrictions eased, testing rebounded. Notably, COVID-19 has been linked to kidney complications, increasing the need for urinalysis:
- Acute Kidney Injury (AKI) in hospitalized patients raises the risk of chronic kidney disease.
- Patients with blood/protein in urine post-COVID require long-term monitoring.
To adapt, regulatory bodies accelerated diagnostic approvals, and companies introduced rapid COVID-19 tests to sustain operations. For example:
- Sysmex America partnered with Siemens Healthineers (2020) to expand distribution of CLINITEK Novus, an automated urine chemistry analyzer.
As vaccination rates rise and healthcare systems stabilize, demand for urinalysis products is expected to grow significantly.
Strategic Insights for Market Success
To thrive in the North America Urinalysis Market, stakeholders should:
- Leverage Data-Driven Analytics – Identify emerging trends, untapped segments, and competitive differentiators.
- Focus on Innovation – Invest in PoC diagnostics, portable devices, and AI-driven urinalysis tools to meet demand for rapid, accurate testing.
- Adapt to Regulatory Shifts – Stay ahead of fast-track approvals and evolving healthcare policies.
- Target Post-COVID Kidney Monitoring – Capitalize on the increased need for renal health assessments in recovered patients.
- Enhance Market Positioning – Develop unique value propositions, such as integrated diagnostic solutions or telehealth-compatible urinalysis platforms.
Future Outlook
The market is poised for long-term growth, driven by technological advancements, rising chronic diseases, and post-pandemic healthcare demands. Companies that anticipate market shifts, invest in R&D, and align with regulatory changes will gain a competitive edge.
By adopting a forward-thinking approach, stakeholders—whether manufacturers, investors, or healthcare providers—can drive profitability and secure a strong market position in North America’s evolving urinalysis landscape.
North America Urinalysis Market Segmentation
North America Urinalysis Market – By Product
- Consumables
- Instruments
North America Urinalysis Market – By Test Type
- Pregnancy and Fertility Tests
- Biochemical Urinalysis
- Sediment Urinalysis
North America Urinalysis Market – By Application
- Disease Screening
- Pregnancy and Fertility
North America Urinalysis Market – By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Research Laboratories and Institutes
North America Urinalysis Market – By Country
- US
- Canada
- Mexico
North America Urinalysis Market – Company Profiles
- Abbott
- ACON Laboratories, Inc.
- ARKRAY, Inc.
- Beckman Coulter, Inc.
- Bio-Rad Laboratories Inc.
- Cardinal Health Inc
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- Siemens Healthineers AG
- Sysmex Corporation
Other Report:
North America Long Read Sequencing Market: https://sites.google.com/view/northamericalongreadsequencing/home
North America Artificial Intelligence in Market: https://penzu.com/p/c83823c9bffd9c4e
North America Multiple Sclerosis Therapeutics Market: https://business-news-insights.blogspot.com/2025/04/north-america-multiple-sclerosis.html
North America Artificial Intelligence (AI) in Healthcare Market: https://sites.google.com/view/artificial-intelligence-na/home
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
